Aortic stenosis trials in France

In France 25 Also abroad 234

17 of 25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in France
Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR
Where
Bordeaux, Marseille, Massy, Rouen, Toulouse
Age
18 years and over
People
300 worldwide
Run by
Abbott Medical Devices
See details and how to joinNCT07696182
No phaseNot yet taking people in France
Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
Where
Nantes
Age
18 years and over
People
250 worldwide
Run by
Montreal Heart Institute
See details and how to joinNCT03303612
No phaseEnrolling by invitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
Where
Pessac, Rennes, Toulouse
Age
18 years and over
People
1,500 worldwide
Run by
Abbott Medical Devices
See details and how to joinNCT05932615
No phaseEnrolling by invitation
Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)
Where
Nice, Toulouse
Age
18 years and over
People
620 worldwide
Run by
Rede Optimus Hospitalar SA
See details and how to joinNCT06898086
No phaseTaking people
LANDMARK Trial: a Randomised Controlled Trial of Myval THV
Where
Créteil, Lille, Massy, Nice, Rennes
Age
18 years and over
People
988 worldwide
Run by
Meril Life Sciences Pvt. Ltd.
See details and how to joinNCT04275726
Phase 2/3Not yet taking people in France
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Where
Grenoble Cedex 9, Lille Cedex, Paris, Paris Cedex 18, Rennes, Saint-Herblain
Age
50 years and over
People
1,276 worldwide
Run by
Kardigan, Inc.
See details and how to joinNCT07001800 · EU 2025-522176-86-01
Phase 2Taking people
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Where
Dijon, Paris Cedex 12, Paris Cedex 13, Paris Cedex 15, Pessac, Poitiers, Rennes
Age
50 years to 80 years
People
502 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05646381 · EU 2022-502135-19-00
Phase 2Taking people
Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort
Where
Brest
Age
18 years and over
People
100
Run by
University Hospital, Brest
See details and how to joinNCT05308888
No phaseTaking people
Prevalence and Significance of ATTR Aortic Valve Amyloidosis in Degenerative Aortic Stenosis
Where
Toulouse
Age
18 years to 99 years
People
100
Run by
University Hospital, Toulouse
See details and how to joinNCT04636684
No phaseTaking people
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
Where
Clermont-Ferrand, Lille, Montpellier, Nîmes, Paris, Pessac, Rennes, Strasbourg, Toulouse
Age
18 years and over
People
944
Run by
University Hospital, Lille
See details and how to joinNCT03728049
Phase 4Taking people
Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation
Where
Besançon, Bordeaux, Brest, Clermont-Ferrand, Lille, Massy, Neuilly-Sur-Seine, Paris, Rennes, Saint-Denis, Saint-Herblain, Strasbourg Cedex, Toulouse Cedex 3
Age
18 years to 110 years
People
2,500 worldwide
Run by
St. Antonius Hospital
See details and how to joinNCT06168370 · EU 2023-504637-42-01
Phase 3Taking people
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Where
Marseille, Nantes, Paris
Age
6 years to 11 years
People
60 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06597019
No phaseTaking people
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
Where
Lille, Lyon, Massy, Rouen, Toulouse
Age
65 years to 75 years
People
1,180 worldwide
Run by
Ceric Sàrl
See details and how to joinNCT06861361
Phase 2/3Taking people
Short versus long antiplatelet therapy after TAVI
Where
Angers, Bordeaux, Caen Cedex 9, Clermont Ferrand Cedex 1, Grenoble Cedex 9, Le Plessis-Robinson, Lille Cedex, Montpellier Cedex 5, Nîmes, Paris, Paris Cedex 13, Paris Cedex 15, Poitiers, Rennes, Rouen Cedex, Saint-Denis, Toulouse, Toulouse Cedex 3, Hopital Privé Saint Martin Recherche Clinique
Age
18 years and over
People
1,400
Run by
Centre Hospitalier Universitaire De Caen Normandie
See details and how to join2023-508208-40-00
Phase 2Taking people
Impact of local tissue inflammation on intramyocardial conduction pathways post percutaneous valve : evaluation by positron emission tomography on exploratory cohort
Where
Brest Cedex 2
Age
18 years and over
People
100
Run by
Centre Hospitalier Regional Et Universitaire De Brest
See details and how to join2024-514587-44-00
Phase 3Taking people
Antagonization of Heparin With Protamine Sulfate After TAVI
Where
Paris
Age
18 years and over
People
940
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06215378
No phaseTaking people
Colibri Transcatheter Aortic Heart Valve System Study
Where
Lille, Massy, Toulouse
Age
75 years and over
People
30 worldwide
Run by
Colibri Heart Valve LLC
See details and how to joinNCT04029844